Wang Bisheng, commander of the Central Epidemic Command Center, said that BNT-related materials have been received, and a preliminary review will be conducted, followed by an emergency use authorization (EUA) review.

(provided by the command center)

[Reporter Lin Huiqin/Taipei Report] China is about to open its borders, and vaccination is an important epidemic prevention tool. The outside world is concerned about the progress of the BA.5 bivalent next-generation vaccine purchase. Wang Bisheng, commander of the Central Epidemic Command Center, said that he has received BNT-related information , an initial review will be conducted, followed by an emergency use authorization (EUA) review, and Moderna is expected to provide relevant information in the near future.

Wang Bisheng pointed out that BNT has received information on the BA.5 bivalent next-generation vaccine from BNT on September 19. The submitted content includes some animal and clinical trials, as well as process information, and will conduct a preliminary review on these, and then do an EUA review. ; they have not yet received their information in the Modena section, but it is reported that they will be provided in the near future.

Please read on...

As for the BA.1 bivalent next-generation vaccine, two batches have arrived. The first batch of 804,000 doses arrived on September 16. After the inspection and sealing procedure is completed, it is expected to be delivered to the county and city governments from tomorrow, giving priority to the elderly over 65 years old, Residents of long-term care institutions and those over 18 years old who are immunocompromised and immunocompromised are vaccinated with supplementary doses; the second batch of 803,000 doses also arrived on September 18, and is expected to be delivered to county and city governments from October.

my country signed a contract for the supply of the Wuhan pneumonia (new coronavirus disease, COVID-19) vaccine with the American company Moderna. It is scheduled to supply 20 million doses of the vaccine this year, and a total of 11.243 million doses have arrived so far.

In addition, the second batch of 504,000 doses of Novavax vaccine arrived today through the COVAX mechanism. Wang Bisheng pointed out that at present, Novavax has not received the unavailability, and there are still 20,000 doses in stock, which should be available in the transition stage.

For related news, see:

"Wuhan Pneumonia Zone", please click here, more relevant information will bring you first-hand grasp.